We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
(+7.2%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$408M |
| 2 |
NVIDIA
NVDA
|
+$395M |
| 3 |
Microsoft
MSFT
|
+$382M |
| 4 |
Amazon
AMZN
|
+$253M |
| 5 |
Palantir
PLTR
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$285M |
| 2 |
NextEra Energy
NEE
|
+$207M |
| 3 |
West Pharmaceutical
WST
|
+$168M |
| 4 |
Broadcom
AVGO
|
+$133M |
| 5 |
Meta Platforms (Facebook)
META
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.42% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KG
2201
Kestrel Group
KG
$71.3M
| $41.9K | ﹤0.01% |
1,240
+408
| +49% | +$13K |
|
2202
Wheels Up
UP
$220M
| $41.7K | ﹤0.01% |
1,263
-432
| -25% | -$18.2K |
|
2203
Compass Therapeutics
CMPX
$373M
| $41.6K | ﹤0.01% |
28,722
+9,451
| +49% | +$15.7K |
|
2204
AbCellera Biologics
ABCL
$1.62B
| $41K | ﹤0.01% |
13,990
-3,422
| -20% | -$9.53K |
|
2205
Entravision Communication
EVC
$983M
| $40.7K | ﹤0.01% |
17,318
+5,699
| +49% | +$13.3K |
|
2206
Destination XL Group
DXLG
$34.7M
| $40.6K | ﹤0.01% |
15,091
+4,967
| +49% | +$13.3K |
|
2207
TScan Therapeutics
TCRX
$51.9M
| $39.9K | ﹤0.01% |
+13,140
| New | +$59.6K |
|
2208
Rimini Street
RMNI
$408M
| $39.9K | ﹤0.01% |
14,942
+4,918
| +49% | +$10K |
|
2209
Holley
HLLY
$314M
| $39.6K | ﹤0.01% |
+13,112
| New | +$36.7K |
|
|
GPMT
2210
Granite Point Mortgage Trust
GPMT
$63.7M
| $39.6K | ﹤0.01% |
+14,179
| New | +$44.6K |
|
|
NVRO
2211
DELISTED
NEVRO CORP.
NVRO
| $38.5K | ﹤0.01% |
10,351
-3,313
| -24% | -$15.3K |
|
2212
GoPro
GPRO
$116M
| $38.4K | ﹤0.01% |
35,247
+11,598
| +49% | +$14.7K |
|
2213
E.W. Scripps
SSP
$274M
| $38.2K | ﹤0.01% |
17,268
+5,819
| +51% | +$13.4K |
|
2214
Blink Charging
BLNK
$75.2M
| $37.7K | ﹤0.01% |
27,095
+8,916
| +49% | +$15.7K |
|
|
VTYX
2215
DELISTED
Ventyx Biosciences
VTYX
| $37.5K | ﹤0.01% |
17,116
+1,457
| +9% | +$3.3K |
|
2216
Lyell Immunopharma
LYEL
$309M
| $37.4K | ﹤0.01% |
2,924
+649
| +29% | +$12.9K |
|
2217
Caribou Biosciences
CRBU
$156M
| $36.8K | ﹤0.01% |
23,170
+2,284
| +11% | +$4.59K |
|
2218
Lexicon Pharmaceuticals
LXRX
$1.02B
| $36.5K | ﹤0.01% |
49,460
+6,404
| +15% | +$7.72K |
|
2219
Sight Sciences
SGHT
$267M
| $36.4K | ﹤0.01% |
+10,004
| New | +$45.6K |
|
2220
HF Foods Group
HFFG
$82.9M
| $36.4K | ﹤0.01% |
+11,339
| New | +$39.7K |
|
2221
Stereotaxis
STXS
$129M
| $36.3K | ﹤0.01% |
15,913
+5,556
| +54% | +$11.6K |
|
|
CVAC
2222
DELISTED
CureVac
CVAC
| $36.2K | ﹤0.01% |
10,627
-2,629
| -20% | -$7.58K |
|
2223
Puma Biotechnology
PBYI
$406M
| $36.2K | ﹤0.01% |
+11,853
| New | +$34.5K |
|
|
QIPT
2224
DELISTED
Quipt Home Medical
QIPT
| $35.5K | ﹤0.01% |
+11,650
| New | +$31.4K |
|
2225
Zura Bio
ZURA
$497M
| $34.7K | ﹤0.01% |
+13,894
| New | +$49.5K |
|
Similar funds
ProShare Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.
- ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
- ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
- ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
- ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
- ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
- ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
- ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.